Mizuho raises Encompass Health price target to $155
The target increase supports a moderately bullish view, but it is an analyst opinion rather than a confirmed catalyst.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The target increase supports a moderately bullish view, but it is an analyst opinion rather than a confirmed catalyst.
What happened, with direct paths to the underlying reporting
Mizuho raised its EHC target to $155 versus the posted price of $135.90, suggesting meaningful analyst-implied upside.
Target: $155
Posted price: $135.9
Analyst firm: Mizuho Securities
Analyst: Ann Hynes
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.